SAVE Trial: Opioid Education for Breast Reconstruction Patients

This study, called the SAVE Trial, is looking at how a special video can help women who are having breast reconstruction surgery after mastectomy (removal of the breast due to cancer or to prevent it). The video teaches you how to use opioid pain medications safely, how to combine them with other pain relievers, and how to properly get rid of any leftover pills. The goal is to see if watching this video helps patients use fewer opioids after surgery and stop using them sooner. You could be eligible if you are a woman aged 18 or older undergoing this specific type of breast reconstruction. The study will compare patients who watch the video to those who receive standard care, to understand how to improve opioid prescribing guidelines.

Study design
This is a randomized controlled trial involving 68 participants. It compares two groups: one that watches an educational video and one that receives standard care.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your opioid use will be measured for up to 2 weeks after your surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07044583

SAVE Trial: SAfe Opioid Use Video Education

Recruiting
NAAges 18+InterventionalSupportive care
University of Utah
~68 participants
Updated 2025-11-26 on ClinicalTrials.gov
What's tested:Opioid Educational Video

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Total Opioid Consumption
Measured over up to 2 weeks postoperative
+1 more outcome measured
Breast Reconstruction
Breast Cancer
1 sites across 1 states
Utah1
  • Jay Agarwal, MD · PRINCIPAL_INVESTIGATOR · Huntsman Cancer Institute

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Female patients 18 years of age or older
Patients undergoing abdominally based autologous free flap breast reconstruction after mastectomy for breast cancer or cancer prophylaxis

Exclusion

Patients undergoing reoperations such as autologous breast reconstruction as a revision procedure following failed implant-based reconstruction
Patients undergoing multiple procedures such as mastectomy and immediate reconstruction
Patients with documented chronic opioid use prior to procedure, chronic pain condition
  • Total Opioid Consumptionup to 2 weeks postoperative

    Total opioid consumption post-discharge from breast reconstruction, measured in Morphine Milligram Equivalents (MMEs).

  • Days to Opioid Cessationup to 2 weeks postoperative

    Total number of days until ceasing opioid use from breast reconstruction surgery to 2 weeks.